3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Carcinoma, Hepatocellular
6
Neoplasm Metastasis
5
Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Lung Neoplasms
2
Cholangiocarcinoma
2
Brain Neoplasms
2
Uveal Melanoma
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcopenia
1
Rectal Neoplasms
1
Radiation Pneumonitis
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Objective Response Rate
1
Neoplasm, Residual
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Locally Advanced Non-small Cell Lung Cancer
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Deglutition Disorders
1
Colorectal Neoplasms
1
Interventions
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
3
Capecitabine
3
Tegafur
2
Stents
2
Radiofrequency Ablation
2
Leucovorin
2
Irinotecan
2
toripalimab
1
tislelizumab
1
taxane
1
surufatinib
1
lenvatinib
1
apixaban
1
apatinib
1
aldesleukin
1
Urination
1
Trastuzumab
1
Tomography, X-Ray Computed
1
Temozolomide
1
Taxes
1
Standard of Care
1
Sorafenib
1
S 1 (combination)
1
Rivaroxaban
1
Radiotherapy
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Gallbladder Neoplasms
×
Immunotherapy
×
Clear all
NCT04333927
2020-06-23
ACCORD
Sun Yat-sen University
Phase 2
Unknown
92 enrolled